XRAY vs. WST
XRAY (DENTSPLY SIRONA Inc.) and WST (West Pharmaceutical Services, Inc.) are both stocks. Both operate in the Medical Instruments & Supplies industry within the Healthcare sector. Over the past 10 years, XRAY returned -13.35%/yr vs 15.91%/yr for WST. Their 0.31 correlation means their historical movements had little consistent relationship.
Performance
XRAY vs. WST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XRAY achieves a 16.97% return, which is significantly lower than WST's 24.21% return. Over the past 10 years, XRAY has underperformed WST with an annualized return of -13.35%, while WST has yielded a comparatively higher 15.91% annualized return.
XRAY
- 1D
- -2.69%
- 1M
- 14.76%
- 6M
- 7.22%
- YTD
- 16.97%
- 1Y
- -3.91%
- 3Y*
- -29.49%
- 5Y*
- -25.78%
- 10Y*
- -13.35%
- ALL TIME*
- 7.42%
WST
- 1D
- 0.40%
- 1M
- -6.71%
- 6M
- 47.73%
- YTD
- 24.21%
- 1Y
- 42.95%
- 3Y*
- -2.56%
- 5Y*
- -3.45%
- 10Y*
- 15.91%
- ALL TIME*
- 11.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $362.83M | $291.60M | $272.21M | |
| $65.33M | $65.69M | $66.12M |
XRAY vs. WST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA Inc. | 16.97% | -36.84% | -45.28% | 13.50% | -42.11% | 7.32% | -6.59% | 53.14% | -43.00% | 14.66% |
WST West Pharmaceutical Services, Inc. | 24.21% | -15.73% | -6.75% | 49.97% | -49.70% | 65.88% | 89.05% | 54.13% | -0.08% | 17.02% |
Correlation
The correlation between XRAY and WST is 0.39, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.39 |
Correlation (3Y) Balances recent behavior with more history. | 0.35 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.41 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.35 |
Correlation (All Time) Calculated using the full available price history since Apr 25, 1991 | 0.31 |
Fundamentals
XRAY:
$2.68B
WST:
$24.00B
XRAY:
-$3.15
WST:
$7.82
XRAY:
0.73
WST:
7.41
XRAY:
2.03
WST:
8.13
XRAY:
$3.68B
WST:
$3.33B
XRAY:
$1.80B
WST:
$1.22B
XRAY:
-$222.00M
WST:
$824.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XRAY vs. WST — Risk / Return Rank
XRAY
WST
XRAY vs. WST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XRAY | WST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | -1.78 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.25 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | 1.75 | -1.86 |
| Martin ratioReturn relative to average drawdown | -0.21 | 3.78 | -3.99 |
Loading charts...
Drawdowns
XRAY vs. WST - Drawdown Comparison
The maximum XRAY drawdown since its inception was -84.45%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for XRAY and WST.
Loading charts...
Drawdown Indicators
| XRAY | WST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.45% | -59.29% | -25.16% |
Max Drawdown (1Y)Largest decline over 1 year | -34.33% | -24.70% | -9.63% |
Max Drawdown (3Y)Largest decline over 3 years | -73.52% | -53.79% | -19.73% |
Max Drawdown (5Y)Largest decline over 5 years | -83.32% | -59.29% | -24.03% |
Max Drawdown (10Y)Largest decline over 10 years | -84.45% | -59.29% | -25.16% |
Current DrawdownCurrent decline from peak | -78.44% | -26.74% | -51.70% |
Average DrawdownAverage peak-to-trough decline | -20.72% | -16.92% | -3.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.58% | 11.41% | +7.17% |
Volatility
XRAY vs. WST - Volatility Comparison
DENTSPLY SIRONA Inc. (XRAY) has a higher volatility of 15.47% compared to West Pharmaceutical Services, Inc. (WST) at 9.56%. This indicates that XRAY's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XRAY | WST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.47% | 9.56% | +5.91% |
Volatility (6M)Calculated over the trailing 6-month period | 35.79% | 24.58% | +11.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.41% | 34.01% | +12.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.24% | 40.73% | -2.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.11% | 34.73% | +0.38% |
Dividends
XRAY vs. WST - Dividend Comparison
XRAY's dividend yield for the trailing twelve months is around 2.39%, more than WST's 0.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.26% | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% |
XRAY DENTSPLY SIRONA Inc. | 2.39% | 5.60% | 3.37% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.94% | 0.53% | 0.54% | 0.48% |
Financials
XRAY vs. WST - Financials Comparison
This section allows you to compare key financial metrics between DENTSPLY SIRONA Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XRAY vs. WST - Profitability Comparison
XRAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, DENTSPLY SIRONA Inc. reported a gross profit of 427.00M and revenue of 880.00M. Therefore, the gross margin over that period was 48.5%.
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, West Pharmaceutical Services, Inc. reported a gross profit of 329.20M and revenue of 872.30M. Therefore, the gross margin over that period was 37.7%.
XRAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, DENTSPLY SIRONA Inc. reported an operating income of -35.00M and revenue of 880.00M, resulting in an operating margin of -4.0%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, West Pharmaceutical Services, Inc. reported an operating income of 179.10M and revenue of 872.30M, resulting in an operating margin of 20.5%.
XRAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, DENTSPLY SIRONA Inc. reported a net income of -10.00M and revenue of 880.00M, resulting in a net margin of -1.1%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, West Pharmaceutical Services, Inc. reported a net income of 154.00M and revenue of 872.30M, resulting in a net margin of 17.7%.
Frequently Asked Questions
XRAY and WST have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XRAY has higher volatility (15.47%) compared to WST (9.56%). In terms of maximum drawdown, XRAY dropped -84.45% vs WST's -59.29%.
WST currently has the higher Sharpe Ratio (1.28 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XRAY and WST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer